AveXis Company Profile (NASDAQ:AVXS)

About AveXis

AveXis logoAveXis, Inc., formerly Biolife Cell Bank, Inc., is a clinical-stage gene therapy company. The Company operates through developing and commercializing gene therapy treatments for patients suffering from neurological genetic diseases segment. The Company's product candidate, AVXS-101, is its gene therapy product candidate that is in a Phase I clinical trial for the treatment of spinal muscular atrophy (SMA) Type 1, which is a genetic disorder characterized by motor neuron loss and associated muscle deterioration. The survival motor neuron (SMN) is a protein for normal motor neuron signaling and function. Patients with SMA Type 1 either carry a mutation in their SMN1 gene or their SMN1 genes have been deleted. AVXS-101 is designed to deliver a functional human SMN gene into the nuclei of motor neurons that then generates an increase in SMN protein levels. It also focuses to develop AVXS-101 to treat additional SMA types and other treatments for rare neurological genetic diseases.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: N/A
  • Sub-Industry: N/A
  • Exchange: NASDAQ
  • Symbol: AVXS
  • CUSIP:
Key Metrics:
  • Previous Close: $42.50
  • 50 Day Moving Average: $38.28
  • 200 Day Moving Average: $34.31
  • 52-Week Range: $23,013,000.00 - $17.40
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -12.83
  • P/E Growth: 0.00
  • Market Cap: $953.43M
  • Outstanding Shares: 23,013,000
Profitability:
  • Return on Equity: -52.81%
  • Return on Assets: -49.14%
Debt:
  • Current Ratio: 15.49%
  • Quick Ratio: 15.49%
Additional Links:
Companies Related to AveXis:

Analyst Ratings

Consensus Ratings for AveXis (NASDAQ:AVXS) (?)
Ratings Breakdown: 5 Buy Ratings
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $47.00 (13.44% upside)

Analysts' Ratings History for AveXis (NASDAQ:AVXS)
Show:
DateFirmActionRatingPrice TargetDetails
9/19/2016Jefferies GroupBoost Price TargetBuy$42.00 -> $50.00View Rating Details
8/17/2016Wells Fargo & Co.UpgradeMarket Perform -> OutperformView Rating Details
8/12/2016Chardan CapitalReiterated RatingBuy$60.00View Rating Details
5/13/2016Goldman Sachs Group Inc.Boost Price TargetBuy$28.00 -> $47.00View Rating Details
3/7/2016BMO Capital MarketsInitiated CoverageOutperform$31.00View Rating Details
(Data available from 9/26/2014 forward)

Earnings

Earnings History for AveXis (NASDAQ:AVXS)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
8/11/2016        
8/11/2016Q216($0.77)($0.68)ViewListenView Earnings Details
5/12/2016Q1($0.35)($1.24)ViewListenView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for AveXis (NASDAQ:AVXS)
Current Year EPS Consensus Estimate: $-3.30 EPS
Next Year EPS Consensus Estimate: $-3.23 EPS
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q3 20161($0.70)($0.70)($0.70)
Q4 20161($0.64)($0.64)($0.64)
(Data provided by Zacks Investment Research)

Dividends

Dividend History for AveXis (NASDAQ:AVXS)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for AveXis (NASDAQ:AVXS)
Institutional Ownership Percentage: 54.46%
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
9/13/2016Paul B ManningInsiderSell289,855$34.50$9,999,997.50View SEC Filing  
2/17/2016Bong Y KohDirectorBuy100,000$20.00$2,000,000.00View SEC Filing  
2/17/2016James E FlynnInsiderBuy750,317$19.47$14,608,671.99View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for AveXis (NASDAQ:AVXS)
DateHeadline
4-traders.com logoAveXis : Announces Proposed Public Offering of 4,000,000 Shares of Common Stock (NASDAQ:AVXS)
www.4-traders.com - September 25 at 3:28 PM
thecountrycaller.com logoAbeona Therapeutics Inc (ABEO): Maxim Group Raised PT Following AAV Licensing (NASDAQ:AVXS)
www.thecountrycaller.com - September 22 at 9:33 AM
fxpips.com logoTop 20 Most Advanced Stocks on NASDAQ (NASDAQ:AVXS)
www.fxpips.com - September 14 at 6:55 AM
streetinsider.com logoAveXis (AVXS) Prices 4.25M Common Stock Offering for Proceeds of ~$128M (NASDAQ:AVXS)
www.streetinsider.com - September 9 at 8:28 AM
4-traders.com logoAveXis : Announces Pricing of Public Offering of Common Stock (NASDAQ:AVXS)
www.4-traders.com - September 9 at 8:28 AM
publicnow.com logoAveXis Announces Pricing of Public Offering of Common Stock (NASDAQ:AVXS)
www.publicnow.com - September 8 at 9:25 AM
streetinsider.com logoAveXis (AVXS) to Offer 4M Shares of Common Stock (NASDAQ:AVXS)
www.streetinsider.com - September 7 at 3:41 PM
biz.yahoo.com logoAVEXIS, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits (NASDAQ:AVXS)
biz.yahoo.com - September 7 at 11:43 AM
publicnow.com logoAveXis Announces Proposed Public Offering of 4,000,000 Shares of Common Stock (NASDAQ:AVXS)
www.publicnow.com - September 6 at 8:49 PM
finance.yahoo.com logoStreet Talk: CREE, AAP & more (NASDAQ:AVXS)
finance.yahoo.com - August 17 at 3:46 PM
benzinga.com logoMorgan Stanley Adjusts Their View Of Biogen After Spinoff (NASDAQ:AVXS)
www.benzinga.com - August 17 at 11:54 AM
benzinga.com logoJefferies Upgrades AveXis To Buy Following Positive AVXS-101 Data, Doc Feedback (NASDAQ:AVXS)
www.benzinga.com - August 12 at 12:17 PM
finance.yahoo.com logoEdited Transcript of AVXS earnings conference call or presentation 11-Aug-16 8:30pm GMT (NASDAQ:AVXS)
finance.yahoo.com - August 12 at 12:17 PM
finance.yahoo.com logoAveXis upgraded by Jefferies (NASDAQ:AVXS)
finance.yahoo.com - August 12 at 12:16 PM
biz.yahoo.com logoAveXis Inc Earnings Call (Q2 2016) (NASDAQ:AVXS)
biz.yahoo.com - August 11 at 9:34 PM
publicnow.com logoAveXis to Report Second Quarter 2016 Financial and Operating Results and Interim Data from Ongoing Phase 1 Trial of AVXS-101 in Spinal Muscular Atrophy Type 1 (NASDAQ:AVXS)
www.publicnow.com - August 2 at 8:29 AM
nasdaq.com logoBigger and better: 2016 IPOs that raised more than $100 million are up over 30% (NASDAQ:AVXS)
www.nasdaq.com - July 22 at 8:40 PM
fxpips.com logoActive Stocks on Major Advance Today – AVXS, ISRG, OPGN, AWH, CTAS, SPU, BGI (NASDAQ:AVXS)
www.fxpips.com - July 21 at 3:41 PM
4-traders.com logoWednesday Sector Leaders: Biotechnology, Drugs (NASDAQ:AVXS)
www.4-traders.com - July 20 at 11:45 AM
globenewswire.com logoAveXis Receives U.S. FDA Breakthrough Therapy Designation for AVXS-101 Gene Replacement Therapy for Spinal Muscular Atrophy Type 1 (NASDAQ:AVXS)
globenewswire.com - July 20 at 11:45 AM
News Icon4 New IPOs This Week Led by Patheon IPO (NYSE: PTHN) (NASDAQ:AVXS)
moneymorning.com - July 18 at 3:44 PM
publicnow.com logoAveXis Appoints Michael B. Johannesen as Senior Vice President, General Counsel and Chief Compliance Officer (NASDAQ:AVXS)
www.publicnow.com - July 11 at 8:13 AM
News IconCure SMA Releases 2016 Updates from Drug Programs in Clinical Trials (NASDAQ:AVXS)
www.curesma.org - June 28 at 9:01 PM
marketwatch.com logoTwilio, other recent IPOs a bright spot among market slump (NASDAQ:AVXS)
www.marketwatch.com - June 27 at 10:03 AM
biz.yahoo.com logoAVEXIS, INC. Files SEC form 8-K, Change in Directors or Principal Officers (NASDAQ:AVXS)
biz.yahoo.com - June 24 at 5:16 PM
breakingfinancenews.com logoAveXis (NASDAQ:AVXS) price target bumped up to $42 as announced today by Jefferies & Co (NASDAQ:AVXS)
breakingfinancenews.com - June 23 at 11:28 AM
benzinga.com logoJefferies Downgrades AveXis, Cites Valuation (NASDAQ:AVXS)
www.benzinga.com - June 22 at 3:39 PM
thestreet.com logoThese 5 Stocks Are Poised for Breakouts (NASDAQ:AVXS)
www.thestreet.com - June 10 at 9:33 AM
publicnow.com logoAveXis to Present at Goldman Sachs Annual Global Healthcare Conference and Jefferies 2016 Healthcare Conference (NASDAQ:AVXS)
www.publicnow.com - June 6 at 5:18 PM
finance.yahoo.com logoAveXis (AVXS) is in Overbought Territory: What's Next? (NASDAQ:AVXS)
finance.yahoo.com - June 2 at 11:04 AM
finance.yahoo.com logoAveXis (AVXS) Looks Good: Stock Adds 6.5% in Session (NASDAQ:AVXS)
finance.yahoo.com - June 2 at 8:40 AM
fxpips.com logoManufacturing Stocks Daily Roundup (NASDAQ:AVXS)
www.fxpips.com - May 23 at 8:06 AM
publicnow.com logoAveXis Presents Pulmonary Data from Ongoing Phase 1 Trial of AVXS-101 in Spinal Muscular Atrophy Type 1 (NASDAQ:AVXS)
www.publicnow.com - May 16 at 8:32 AM
biz.yahoo.com logoAVEXIS, INC. Files SEC form 10-Q, Quarterly Report (NASDAQ:AVXS)
biz.yahoo.com - May 13 at 4:29 PM
finance.yahoo.com logoEdited Transcript of AVXS earnings conference call or presentation 12-May-16 8:30pm GMT (NASDAQ:AVXS)
finance.yahoo.com - May 13 at 9:25 AM
finance.yahoo.com logoAveXis (AVXS) Shares March Higher, Can It Continue? (NASDAQ:AVXS)
finance.yahoo.com - May 12 at 5:04 PM
finance.yahoo.com logoAveXis Reports First Quarter 2016 Financial and Operating Results (NASDAQ:AVXS)
finance.yahoo.com - May 12 at 4:01 PM
biz.yahoo.com logoAveXis Inc Earnings Call (Q1 2016) (NASDAQ:AVXS)
biz.yahoo.com - May 12 at 7:44 AM
biz.yahoo.com logoQ1 2016 AveXis Inc Earnings Release - After Market Close (NASDAQ:AVXS)
biz.yahoo.com - May 12 at 7:07 AM
finance.yahoo.com logoDrug Stocks' Earnings Slated for This Week: RDY, AVXS, ESALY (NASDAQ:AVXS)
finance.yahoo.com - May 11 at 10:03 AM
finance.yahoo.com logoDrug Stocks' Earnings Slated for This Week: RDY, AVXS, ESALY (NASDAQ:AVXS)
finance.yahoo.com - May 11 at 10:03 AM
fxpips.com logoAveXis (AVXS), Argos (ARGS), Depomed (DEPO) Top Moving Stocks at the Close (NASDAQ:AVXS)
www.fxpips.com - May 10 at 8:08 AM
4-traders.com logoREMINDER/Media Advisory: Correctional Service of Canada Invites Media to Tour Collins Bay Institution (NASDAQ:AVXS)
www.4-traders.com - May 6 at 5:18 PM
streetinsider.com logoAveXis (AVXS) Announces Phase 1 Trial Data for AVXS-101 in SMA Type 1 (NASDAQ:AVXS)
www.streetinsider.com - May 6 at 5:18 PM
publicnow.com logoAveXis Reports Data from Ongoing Phase 1 Trial of AVXS-101 in Spinal Muscular Atrophy Type 1 (NASDAQ:AVXS)
www.publicnow.com - May 6 at 3:34 PM
biz.yahoo.com logoAVEXIS, INC. Files SEC form 8-K, Regulation FD Disclosure, Other Events, Financial Statements and Exhibits (NASDAQ:AVXS)
biz.yahoo.com - May 6 at 3:11 PM
finance.yahoo.com logo3:11 pm AveXis presents an interim analysis of data as of April 1 from the ongoing Phase 1 trial of AVXS-101 for the treatment of spinal muscular atrophy Type 1 (NASDAQ:AVXS)
finance.yahoo.com - May 6 at 3:11 PM
biz.yahoo.com logoOverseas Shipholding Group Inc Earnings Call scheduled for 4:30 pm ET today (NASDAQ:AVXS)
biz.yahoo.com - May 6 at 12:40 AM
publicnow.com logoAveXis to Report First Quarter 2016 Financial Results on Thursday, May 12 (NASDAQ:AVXS)
www.publicnow.com - May 5 at 8:21 AM
nasdaq.com logoAZN Breathes Easy, EXEL Scores FDA Nod, SRPT Disappointed, PETX On The Rise (NASDAQ:AVXS)
www.nasdaq.com - April 26 at 7:49 AM

Social

AveXis (NASDAQ:AVXS) Chart for Monday, September, 26, 2016


Last Updated on 9/26/2016 by MarketBeat.com Staff